Literature DB >> 23543327

Pulmonary function in ankylosing spondylitis: association with clinical variables.

A J L Brambila-Tapia1, A D Rocha-Muñoz, L Gonzalez-Lopez, M Vázquez-Del-Mercado, M Salazar-Páramo, I P Dávalos-Rodríguez, L De la Cerda-Trujillo, M L Diaz-Toscano, P Hernandez-Cuervo, V Diaz-Rizo, D Sanchez-Mosco, J C Vazquez-Jimenez, E G Cardona-Muñoz, J I Gamez-Nava.   

Abstract

To evaluate the association between pulmonary function and clinical variables in ankylosing spondylitis (AS) and to compare the pulmonary function of patients with AS with that of healthy controls, 61 AS patients and 74 healthy controls were included. In AS, we assessed clinical disease indices (BASDAI, BASFI, BASG), morning stiffness, number of hypersensitive entheses, metrology measures, 6-min walking test, acute phase reactants, radiological presence of "bamboo spine," and severity of radiological involvement in sacroiliac and vertebral joints. AS and healthy controls had similar age and gender. All the parameters of pulmonary function were significantly diminished in AS than in healthy controls (p < 0.001), with a higher proportion of restrictive pattern (57.4 vs. 5.4 %). In AS, pulmonary function correlated negatively with BASDAI, BASFI, BASG, morning stiffness, number of hypersensitive entheses, occiput-wall distance, and ESR, and positively with 6-min walking test. There was no association between pulmonary function with radiological stage of vertebral joints and sacroiliac joints, "bamboo spine," disease duration, or chest expansion. A higher frequency of AS patients had a decreased pulmonary function and results of the 6-min walking test. These abnormalities in AS were more related with disease activity than with mobility limitation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543327     DOI: 10.1007/s00296-013-2723-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing.

Authors:  Abdellah El Maghraoui; Souad Chaouir; Ahmed Abid; Ahmed Bezza; Fatima Tabache; Lahsen Achemlal; Ali Abouzahir; Driss Ghafir; Victor Ohayon; Moulay Idriss Archane
Journal:  Clin Rheumatol       Date:  2004-02-24       Impact factor: 2.980

Review 2.  Pleuropulmonary involvement in ankylosing spondylitis.

Authors:  Abdellah El Maghraoui
Journal:  Joint Bone Spine       Date:  2005-12       Impact factor: 4.929

3.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

4.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

5.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

6.  An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis.

Authors:  R Carter; P Riantawan; S W Banham; R D Sturrock
Journal:  Respir Med       Date:  1999-10       Impact factor: 3.415

7.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

10.  Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study.

Authors:  Gunnhild Berdal; Silje Halvorsen; Désirée van der Heijde; Morten Mowe; Hanne Dagfinrud
Journal:  Arthritis Res Ther       Date:  2012-01-25       Impact factor: 5.156

View more
  4 in total

Review 1.  Systemic changes associated with quality of life after surgical treatment of kyphotic deformity in patients with ankylosing spondylitis: a systematic review.

Authors:  Jingwei Liu; Nan Kang; Yiqi Zhang; Yong Hai
Journal:  Eur Spine J       Date:  2020-02-04       Impact factor: 3.134

2.  Gait as predictor of physical function in axial spondyloarthritis: the prospective longitudinal FOLOMI (Function, Locomotion, Measurement, Inflammation) study protocol.

Authors:  Julie Soulard; Nicolas Vuillerme; Philippe Gaudin; Laurent Grange; Athan Baillet; Jean-Luc Cracowski; Robert Juvin; Jacques Vaillant
Journal:  Rheumatol Int       Date:  2019-08-07       Impact factor: 2.631

3.  The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?

Authors:  Ilaria Pagnini; Mariangela Scavone; Ilaria Maccora; Maria Vincenza Mastrolia; Edoardo Marrani; Federico Bertini; Lovro Lamot; Gabriele Simonini
Journal:  Front Med (Lausanne)       Date:  2021-05-13

4.  Influence of Anti-TNF and Disease Modifying Antirheumatic Drugs Therapy on Pulmonary Forced Vital Capacity Associated to Ankylosing Spondylitis: A 2-Year Follow-Up Observational Study.

Authors:  Alberto Daniel Rocha-Muñoz; Aniel Jessica Leticia Brambila-Tapia; María Guadalupe Zavala-Cerna; José Clemente Vásquez-Jiménez; Liliana Faviola De la Cerda-Trujillo; Mónica Vázquez-Del Mercado; Norma Alejandra Rodriguez-Jimenez; Valeria Díaz-Rizo; Viviana Díaz-González; Ernesto German Cardona-Muñoz; Ingrid Patricia Dávalos-Rodríguez; Mario Salazar-Paramo; Jorge Ivan Gamez-Nava; Arnulfo Hernan Nava-Zavala; Laura Gonzalez-Lopez
Journal:  J Immunol Res       Date:  2015-05-19       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.